Bio Rad Laboratories Inc
Change company Symbol lookup
Select an option...
BIO Bio Rad Laboratories Inc
VTNR Vertex Energy Inc
BFI Burgerfi International Inc
ATRO Astronics Corp
BHR Braemar Hotels & Resorts Inc
NBSTU Newbury Street Acquisition Corp
SKX Skechers USA Inc
IGICW International General Insurance Holdings Equity Warrants 17th March 2025 *W EXP 03/17/2025
NHIC Newhold Investment II Corp
MMI Marcus & Millichap Inc
Go

Health Care : Life Sciences Tools & Services | Mid Cap Growth
Company profile

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. Its segments include Life Science and Clinical Diagnostics. Its Life Science segment markets and develops, manufactures and markets approximately 9,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Its Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. It supplies approximately 3,000 different products that cover over 300 clinical diagnostic tests to the in vitro diagnostics (IVD) test market.

Closing Price
$495.16
Day's Change
-12.53 (-2.47%)
Bid
--
Ask
--
B/A Size
--
Day's High
513.45
Day's Low
495.05
Volume
(Average)
Volume:
173,156

10-day average volume:
176,998
173,156

Company Profile

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. Its segments include Life Science and Clinical Diagnostics. Its Life Science segment markets and develops, manufactures and markets approximately 9,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Its Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. It supplies approximately 3,000 different products that cover over 300 clinical diagnostic tests to the in vitro diagnostics (IVD) test market.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
5.19x
Price/Book (MRQ)
1.49x
Price/Cash Flow (TTM)
469.69x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

June 2022
Current Month
414.7K
Previous Month
563.3K
Percent of Float
1.95%
Days to Cover
2.8105 Days

Share Information

BIO is in a share class of common stock
Float
21.5M
Shares Outstanding
29.9M
Institutions Holding Shares
776
78.35%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Norman D. SchwartzChmn.
  • Ilan DaskalCFO
  • Andrew J. LastCOO
  • Timothy Scott ErnstExec.VP
  • Michael CrowleyExec.VP

Address

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.